BR0312896A - Glicanos e glicopeptìdeos de campylobacter - Google Patents
Glicanos e glicopeptìdeos de campylobacterInfo
- Publication number
- BR0312896A BR0312896A BR0312896-2A BR0312896A BR0312896A BR 0312896 A BR0312896 A BR 0312896A BR 0312896 A BR0312896 A BR 0312896A BR 0312896 A BR0312896 A BR 0312896A
- Authority
- BR
- Brazil
- Prior art keywords
- galnac
- glycan
- campylobacter
- bac
- antibodies
- Prior art date
Links
- 241000589876 Campylobacter Species 0.000 title abstract 3
- 102000002068 Glycopeptides Human genes 0.000 title abstract 3
- 108010015899 Glycopeptides Proteins 0.000 title abstract 3
- 150000004676 glycans Chemical class 0.000 abstract 5
- 206010051226 Campylobacter infection Diseases 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 abstract 1
- 238000005004 MAS NMR spectroscopy Methods 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- NRXWTRNYICXMBF-CACQUXPASA-N n-[(2r,3s,4s,5r)-5-acetamido-4,6-dihydroxy-2-methyloxan-3-yl]acetamide Chemical compound C[C@H]1OC(O)[C@H](NC(C)=O)[C@@H](O)[C@@H]1NC(C)=O NRXWTRNYICXMBF-CACQUXPASA-N 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39973502P | 2002-08-01 | 2002-08-01 | |
| PCT/CA2003/001156 WO2004013151A2 (en) | 2002-08-01 | 2003-07-30 | Campylobacter glycans and glycopeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0312896A true BR0312896A (pt) | 2005-06-14 |
Family
ID=31495764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0312896-2A BR0312896A (pt) | 2002-08-01 | 2003-07-30 | Glicanos e glicopeptìdeos de campylobacter |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7598354B2 (https=) |
| EP (1) | EP1527080B1 (https=) |
| JP (1) | JP4718174B2 (https=) |
| CN (1) | CN1671722A (https=) |
| AU (1) | AU2003254665C1 (https=) |
| BR (1) | BR0312896A (https=) |
| CA (1) | CA2494223C (https=) |
| ES (1) | ES2391525T3 (https=) |
| WO (1) | WO2004013151A2 (https=) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214660B2 (en) * | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| KR20090110951A (ko) | 2002-03-07 | 2009-10-23 | 아이드게노쉬쉐 테흐니쉐 호흐슐레 쥬리히 | 원핵 숙주에서의 재조합 글리코실화 단백질 생산 방법 및 생산계 |
| AU2002952121A0 (en) * | 2002-10-17 | 2002-10-31 | Alchemia Limited | Novel carbohydrate based anti-bacterials |
| EP2055189A1 (en) | 2003-04-09 | 2009-05-06 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
| US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
| US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
| US20080015142A1 (en) * | 2003-12-03 | 2008-01-17 | Defrees Shawn | Glycopegylated Follicle Stimulating Hormone |
| WO2006010143A2 (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| US20080176790A1 (en) | 2004-10-29 | 2008-07-24 | Defrees Shawn | Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf) |
| US9029331B2 (en) | 2005-01-10 | 2015-05-12 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
| US20070154992A1 (en) | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| CA2607595C (en) * | 2005-05-11 | 2018-11-27 | Eth Zuerich | Recombinant n-glycosylated proteins from procaryotic cells |
| US20070105755A1 (en) * | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| WO2007056191A2 (en) | 2005-11-03 | 2007-05-18 | Neose Technologies, Inc. | Nucleotide sugar purification using membranes |
| ES2516694T3 (es) | 2006-07-21 | 2014-10-31 | Ratiopharm Gmbh | Glicosilación de péptidos a través de secuencias de glicosilación con unión en O |
| US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
| KR20100016160A (ko) | 2007-04-03 | 2010-02-12 | 바이오제너릭스 에이지 | 글리코페길화 ｇ―ｃｓｆ를 이용하는 치료 방법 |
| WO2008154639A2 (en) | 2007-06-12 | 2008-12-18 | Neose Technologies, Inc. | Improved process for the production of nucleotide sugars |
| CN107119095B (zh) | 2008-01-03 | 2022-07-05 | 康乃尔研究基金会有限公司 | 原核生物中的糖基化蛋白表达 |
| CA2711503A1 (en) * | 2008-01-08 | 2009-07-16 | Biogenerix Ag | Glycoconjugation of polypeptides using oligosaccharyltransferases |
| HRP20181259T1 (hr) | 2008-02-20 | 2018-10-05 | Glaxosmithkline Biologicals S.A. | Biokonjugati načinjeni iz rekombinantnih n-glikoziliranih proteina iz prokariotskih stanica |
| KR101582841B1 (ko) | 2008-02-27 | 2016-01-11 | 노보 노르디스크 에이/에스 | 콘쥬게이트된 인자 ｖｉｉｉ 분자 |
| EP2411503B1 (en) | 2009-03-27 | 2017-09-13 | Eidgenössische Technische Hochschule Zürich | Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
| EP2501406B8 (en) | 2009-11-19 | 2018-01-24 | GlaxoSmithKline Biologicals S.A. | Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| ES2535543T3 (es) | 2010-02-11 | 2015-05-12 | The Governors Of The University Of Alberta | Compuestos de glicano N-enlazado |
| US8841099B2 (en) * | 2010-04-20 | 2014-09-23 | National Research Council Of Canada | Cell-based production of nonulosonates |
| JP6339366B2 (ja) | 2010-05-06 | 2018-06-06 | グリコヴァキシン アーゲー | 莢膜グラム陽性菌のバイオコンジュゲートワクチン |
| US9308246B2 (en) | 2010-05-28 | 2016-04-12 | The United States Of America As Represented By The Secretary Of The Navy | Capsule composition for use as immunogen against Campylobacter jejuni |
| JP6135046B2 (ja) * | 2012-04-20 | 2017-05-31 | 株式会社島津製作所 | 糖ペプチドの質量分析法 |
| US10258680B2 (en) | 2013-04-05 | 2019-04-16 | The Governors Of The University Of Alberta | Campylobacter vaccine |
| JP6722697B2 (ja) * | 2015-01-26 | 2020-07-15 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
| WO2017117539A1 (en) | 2015-12-30 | 2017-07-06 | Northwestern University | Cell-free glycoprotein synthesis (cfgps) in prokaryotic cell lysates enriched with components for glycosylation |
| US10829795B2 (en) | 2016-07-14 | 2020-11-10 | Northwestern University | Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates |
| WO2019035916A1 (en) | 2017-08-15 | 2019-02-21 | Northwestern University | DESIGN OF PROTEIN GLYCOSYLATION SITES BY RAPID EXPRESSION AND CHARACTERIZATION OF N-GLYCOSYLTRANSFERASES |
| WO2019119134A1 (en) * | 2017-12-19 | 2019-06-27 | The Governors Of The University Of Alberta | Clostridium perfringens surface glycans and uses thereof |
| US11530432B2 (en) | 2018-03-19 | 2022-12-20 | Northwestern University | Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates |
| WO2019204346A1 (en) | 2018-04-16 | 2019-10-24 | Northwestern University | METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELLLYSATES |
| US12098433B2 (en) | 2018-08-03 | 2024-09-24 | Northwestern University | On demand, portable, cell-free molecular sensing platform |
| CA3126492A1 (en) | 2019-01-11 | 2020-07-16 | Northwestern University | Bioconjugate vaccines synthesis in prokaryotic cell lysates |
| WO2020185451A2 (en) | 2019-03-04 | 2020-09-17 | Northwestern University | Riboswitch-based fluoride sensing in cell-free extract |
| US12226410B2 (en) | 2019-10-18 | 2025-02-18 | Northwestern University | Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6 |
| US12503715B2 (en) | 2019-10-25 | 2025-12-23 | Northwestern University | Cell-free extract preparation protocol for enrichment of membrane vesicles and increased glycoprotein yields |
| US20240287564A1 (en) * | 2021-06-07 | 2024-08-29 | The University Of British Columbia | Acholetin biopolymers and methods for enzymatic synthesis |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925796A (en) * | 1986-03-07 | 1990-05-15 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
| US5200344A (en) * | 1990-11-13 | 1993-04-06 | Blaser Martin J | Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens |
| CA2167691A1 (en) * | 1993-08-27 | 1995-03-02 | Martin J. Blaser | Campylobacter jejuni antigens, and methods for their production and use |
| US5882902A (en) * | 1994-09-06 | 1999-03-16 | Bioflexin Ab | Amino acid conjugate |
| US5840547A (en) * | 1995-01-05 | 1998-11-24 | Ramot University Authority For Applied Research & Indfustrial Development Ltd. | Bioemulsifiers |
| US6676946B2 (en) * | 1997-03-27 | 2004-01-13 | Institut Pasteur | Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof |
| US6699705B2 (en) * | 1999-02-01 | 2004-03-02 | National Research Council Of Canada | Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
| EP1159002A2 (en) * | 1999-03-05 | 2001-12-05 | Trustees Of Tufts College | Emulsan and emulsan analogs immunization formulations and use |
| US6512014B2 (en) * | 2000-12-13 | 2003-01-28 | Ramot University Authority For Applied Research And Industrial Development Limited | Compositions containing bioemulsifiers and a method for their preparation |
| EP2042196B1 (en) * | 2001-10-10 | 2016-07-13 | ratiopharm GmbH | Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| US20030232401A1 (en) * | 2002-06-12 | 2003-12-18 | Pugia Michael J. | Bacterial test method by glycated label binding |
| AU2006295017B2 (en) * | 2005-09-21 | 2010-06-17 | The United States Of America As Represented By The Secretary Of The Navy | Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni |
-
2003
- 2003-07-30 EP EP03766087A patent/EP1527080B1/en not_active Expired - Lifetime
- 2003-07-30 CA CA2494223A patent/CA2494223C/en not_active Expired - Lifetime
- 2003-07-30 ES ES03766087T patent/ES2391525T3/es not_active Expired - Lifetime
- 2003-07-30 BR BR0312896-2A patent/BR0312896A/pt not_active IP Right Cessation
- 2003-07-30 JP JP2004525093A patent/JP4718174B2/ja not_active Expired - Fee Related
- 2003-07-30 WO PCT/CA2003/001156 patent/WO2004013151A2/en not_active Ceased
- 2003-07-30 US US10/523,459 patent/US7598354B2/en not_active Expired - Lifetime
- 2003-07-30 CN CNA038181851A patent/CN1671722A/zh active Pending
- 2003-07-30 AU AU2003254665A patent/AU2003254665C1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JP4718174B2 (ja) | 2011-07-06 |
| AU2003254665C1 (en) | 2010-08-19 |
| US20060165728A1 (en) | 2006-07-27 |
| CA2494223C (en) | 2012-10-02 |
| EP1527080B1 (en) | 2012-06-20 |
| ES2391525T3 (es) | 2012-11-27 |
| WO2004013151A2 (en) | 2004-02-12 |
| JP2005534752A (ja) | 2005-11-17 |
| EP1527080A2 (en) | 2005-05-04 |
| AU2003254665A1 (en) | 2004-02-23 |
| AU2003254665B2 (en) | 2010-01-28 |
| CA2494223A1 (en) | 2004-02-12 |
| CN1671722A (zh) | 2005-09-21 |
| WO2004013151A3 (en) | 2004-07-01 |
| US7598354B2 (en) | 2009-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0312896A (pt) | Glicanos e glicopeptìdeos de campylobacter | |
| Rott et al. | Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders | |
| León-Sicairos et al. | Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme | |
| Hoyle | The influenza viruses | |
| Paba et al. | Proteomic analysis of the human pathogen Trypanosoma cruzi | |
| Goldsmit et al. | An improved method for the isolation and identification of bluetongue virus by intravenous inoculation of embryonating chicken eggs | |
| Zhai et al. | Enhanced immune responses of chickens to oral vaccination against infectious bursal disease by ginseng stem-leaf saponins | |
| BR9912178A (pt) | Vacinas de peptìdeo sintéticas para febre aftosa | |
| BR0012919A (pt) | Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv | |
| Bittar et al. | Effects of injectable trace minerals on the immune response to Mannheimia haemolytica and Pasteurella multocida following vaccination of dairy calves with a commercial attenuated-live bacterin vaccine | |
| WO2021233885A1 (en) | Mimotope peptides of the spike protein from the sars-cov-2 virus | |
| Hajnicka et al. | Tick salivary gland extracts promote virus growth in vitro | |
| US20200069781A1 (en) | Immunogenic lhrh composition and use thereof in pigs | |
| Acosta et al. | Structural and immunological characterization of sulphatides: relevance of sulphate moieties in Trypanosoma cruzi glycoconjugates | |
| LEACH et al. | A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants | |
| Neurath et al. | Solubilization and some properties of the erythrocyte receptor for adenovirus type 7 haemagglutinin | |
| US20240218020A1 (en) | Peptides inhibiting covid-19 | |
| Housawi et al. | A close comparative study on the response of sheep and goats to experimental orf infection | |
| CN1341150A (zh) | 疟疾疫苗 | |
| US4083959A (en) | Therapeutical method for treating infection of mink hemorrhagic pneumonitis | |
| Qureshi et al. | A novel phage based marker vaccine and DI VA assay for hemorrhagic septicemia in bovines | |
| Purdy et al. | Conglutinin and immunoconglutinin titers in stressed calves in a feedlot | |
| Peter et al. | Detection of bovine viral diarrhea virus antibodies in camels (Camelus dromedarius) in Maiduguri, Nigeria | |
| US12285479B2 (en) | Anti-coronavirus vaccines | |
| BRPI0503187B1 (pt) | Composição compreendendo fucose manose ligand (fml) e saponina, para uso como uma vacina bloqueadora contra a transmissão de leishmaniose visceral canina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2162 DE 12/06/2012. |